litlas
Log inCreate account

John C. Cheville

Active 1992–2026

226
Papers
34,112
Citations
106
h-index
213
i10-index

Citations

Citations per year for John C. Cheville1956: 2 citations1978: 1 citations1984: 1 citations1996: 3 citations1997: 6 citations1998: 8 citations1999: 27 citations2000: 32 citations2001: 58 citations2002: 63 citations2003: 102 citations2004: 174 citations2005: 215 citations2006: 228 citations2007: 297 citations2008: 309 citations2009: 274 citations2010: 256 citations2011: 254 citations2012: 258 citations2013: 263 citations2014: 299 citations2015: 320 citations2016: 309 citations2017: 275 citations2018: 285 citations2019: 809 citations2020: 911 citations2021: 797 citations2022: 625 citations2023: 393 citations2024: 678 citations2025: 304 citations2026: 9 citations1957–1977: no citations, so these years are not shown1979–1983: no citations, so these years are not shown1985–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,204 citing papers, 29.5% of this breakdownChina: 1,161 citing papers, 10.7% of this breakdownItaly: 631 citing papers, 5.8% of this breakdownUnited Kingdom: 543 citing papers, 5% of this breakdownGermany: 513 citing papers, 4.7% of this breakdownCanada: 477 citing papers, 4.4% of this breakdownFrance: 440 citing papers, 4.1% of this breakdownJapan: 429 citing papers, 4% of this breakdownSpain: 295 citing papers, 2.7% of this breakdownNetherlands: 276 citing papers, 2.5% of this breakdownAustralia: 240 citing papers, 2.2% of this breakdownSwitzerland: 213 citing papers, 2% of this breakdown
0%29.5%Other 22.4%

Institutions

Fields

  • Medicine74.6%
  • Biochemistry, Genetics and Molecular Biology18.1%
  • Immunology and Microbiology3.7%
  • Computer Science1.4%
  • Engineering0.6%
  • Neuroscience0.4%
  • Other1.2%

Topics

  • Renal cell carcinoma treatment11%
  • Cancer Immunotherapy and Biomarkers6.2%
  • Bladder and Urothelial Cancer Treatments5.8%
  • Renal and related cancers4.2%
  • Immunotherapy and Immune Responses2.9%
  • Prostate Cancer Treatment and Research2.7%
  • Other67.2%

Coauthors

All papers

Open in search
  1. The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Authors: Brett Delahunt, John C. Cheville, Guido Martignoni, Peter A. Humphrey, Cristina Magi‐Galluzzi, Jesse K. McKenney, Lars Egevad, Ferrán Algaba, Holger Moch, David J. Grignon, Rodolfo Montironi, John R. Srigley - The American Journal of Surgical Pathology 2013 cited by 856

  2. USP10 Regulates p53 Localization and Stability by Deubiquitinating p53

    Authors: Jian Yuan, Kuntian Luo, Lizhi Zhang, John C. Cheville, Zhenkun Lou - Cell 2010 cited by 654

  3. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer

    Authors: Jonathan I. Epstein, Mahul B. Amin, Samson W. Fine, Ferrán Algaba, Manju Aron, Dilek Ertoy Baydar, Antonio López-Beltrán, Fadi Brimo, John C. Cheville, Maurizio Colecchia, Éva Compérat, Isabela Werneck da Cunha, Warick Delprado, Angelo M. De Marzo, Giovanna A. Giannico, Jennifer Gordetsky, Charles C. Guo, Donna E. Hansel, Michelle S. Hirsch, Jiaoti Huang, Peter A. Humphrey, Rafael E. Jiménez, Francesca Khani, Qingnuan Kong, Oleksandr N. Kryvenko, Lakshmi P. Kunju, Priti Lal, Mathieu Latour, Tamara Lotan, Fiona Maclean, Cristina Magi‐Galluzzi, Rohit Mehra, Santosh Menon, Hiroshi Miyamoto, Rodolfo Montironi, George J. Netto, Jane Nguyen, Adeboye O. Osunkoya, Anil V. Parwani, Brian D. Robinson, Mark A. Rubin, Rajal B. Shah, Jeffrey So, Hiroyuki Takahashi, Fabio Tavora, Maria Tretiakova, Lawrence D. True, Sara E. Wobker, Ximing J. Yang, Ming Zhou, Debra L. Zynger, Kiril Trpkov - Archives of Pathology & Laboratory Medicine 2020 cited by 276

  4. Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma

    Authors: Bradley C. Leibovich, Christine M. Lohse, Paul L. Crispen, Stephen A. Boorjian, R. Houston Thompson, Michael L. Blute, John C. Cheville - The Journal of Urology 2010 cited by 460

  5. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma

    Authors: Bradley C. Leibovich, Michael L. Blute, John C. Cheville, Christine M. Lohse, Igor Frank, Eugene D. Kwon, Amy L. Weaver, Alexander S. Parker, Horst Zincke - Cancer 2003 cited by 831

  6. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

    Authors: Kiril Trpkov, Sean R. Williamson, Anthony J. Gill, Adebowale Adeniran, Abbas Agaimy, Reza Alaghehbandan, Mahul B. Amin, Pedram Argani, Ying‐Bei Chen, Liang Cheng, Jonathan I. Epstein, John C. Cheville, Éva Compérat, Isabela Werneck da Cunha, Jennifer Gordetsky, Sounak Gupta, Huiying He, Michelle S. Hirsch, Peter A. Humphrey, Payal Kapur, Fumiyoshi Kojima, José I. López, Fiona Maclean, Cristina Magi‐Galluzzi, Jesse K. McKenney, Rohit Mehra, Santosh Menon, George J. Netto, Christopher G. Przybycin, Priya Rao, Qiu Rao, Victor E. Reuter, Rola Saleeb, Rajal B. Shah, Steven C. Smith, Satish K. Tickoo, Maria Tretiakova, Lawrence D. True, Virginie Verkarre, Sara E. Wobker, Ming Zhou, Ondřej Hes - Modern Pathology 2021 cited by 220

  7. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

    Authors: Michael L. Blute, Bradley C. Leibovich, Christine M. Lohse, John C. Cheville, Horst Zincke - British Journal of Urology 2004 cited by 697

  8. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis

    Authors: Divyanshu Dubey, Michael R. Wilson, Benjamin D. Clarkson, Caterina Giannini, Manish J. Gandhi, John C. Cheville, Vanda A. Lennon, Scott D.Z. Eggers, Michelle F. Devine, Caleigh Mandel‐Brehm, Thomas J. Kryzer, Shannon R. Hinson, Khashayarsha Khazaie, Chadwick M. Hales, Jorge C. Kattah, Kevin D. Pavelko, Patrick Andrews, James Eaton, Jiraporn Jitprapaikulsan, John R. Mills, Eoin P. Flanagan, Αναστασία Ζεκερίδου, Bradley C. Leibovich, James P. Fryer, Matthew Torre, CHARLES I. KAUFMAN, James B. Thoreson, Jessica Sagen, Jenny Linnoila, Joseph L. DeRisi, Charles L. Howe, Andrew McKeon, Sean J. Pittock - JAMA Neurology 2020 cited by 179

  9. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

    Authors: Kiril Trpkov, Ondřej Hes, Sean R. Williamson, Adebowale Adeniran, Abbas Agaimy, Reza Alaghehbandan, Mahul B. Amin, Pedram Argani, Ying‐Bei Chen, Liang Cheng, Jonathan I. Epstein, John C. Cheville, Éva Compérat, Isabela Werneck da Cunha, Jennifer Gordetsky, Sounak Gupta, Huiying He, Michelle S. Hirsch, Peter A. Humphrey, Payal Kapur, Fumiyoshi Kojima, José I. López, Fiona Maclean, Cristina Magi‐Galluzzi, Jesse K. McKenney, Rohit Mehra, Santosh Menon, George J. Netto, Christopher G. Przybycin, Priya Rao, Qiu Rao, Victor E. Reuter, Rola Saleeb, Rajal B. Shah, Steven C. Smith, Satish K. Tickoo, Maria Tretiakova, Lawrence D. True, Virginie Verkarre, Sara E. Wobker, Ming Zhou, Anthony J. Gill - Modern Pathology 2021 cited by 250

  10. Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma

    Authors: Xavier Frigola, Brant A. Inman, Christine M. Lohse, Christopher J. Krco, John C. Cheville, R. Houston Thompson, Bradley C. Leibovich, Michael L. Blute, Haidong Dong, Eugene D. Kwon - Clinical Cancer Research 2011 cited by 356

  11. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery

    Authors: Bradley C. Leibovich, Christine M. Lohse, John C. Cheville, Harras B. Zaid, Stephen A. Boorjian, Igor Frank, R. Houston Thompson, William P. Parker - European Urology 2018 cited by 229

  12. An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign Score

    Authors: Igor Frank, Michael L. Blute, John C. Cheville, Christine M. Lohse, Amy L. Weaver, Horst Zincke - The Journal of Urology 2002 cited by 1,138

  13. Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma

    Authors: John C. Cheville, Christine M. Lohse, Horst Zincke, Amy L. Weaver, Michael L. Blute - The American Journal of Surgical Pathology 2003 cited by 1,091

  14. Sarcomatoid Renal Cell Carcinoma

    Authors: John C. Cheville, Christine M. Lohse, Horst Zincke, Amy L. Weaver, Bradley C. Leibovich, Igor Frank, Michael L. Blute - The American Journal of Surgical Pathology 2004 cited by 416

  15. Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size

    Authors: Igor Frank, Michael L. Blute, John C. Cheville, Christine M. Lohse, Amy L. Weaver, Horst Zincke - The Journal of Urology 2003 cited by 1,074

  16. Infrared spectroscopic laser scanning confocal microscopy for whole-slide chemical imaging

    Authors: Kevin Yeh, Ishaan Sharma, Kianoush Falahkheirkhah, Matthew P. Confer, Andres C. Orr, Yen‐Ting Liu, Yamuna Phal, Ruo-Jing Ho, Manu Mehta, Ankita Bhargava, Wenyan Mei, Georgina Cheng, John C. Cheville, Rohit Bhargava - Nature Communications 2023 cited by 46

  17. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortality

    Authors: Sarah P. Psutka, Alonso Carrasco, Grant D. Schmit, Michael R. Moynagh, Stephen A. Boorjian, Igor Frank, Suzanne Stewart, Prabin Thapa, Robert F. Tarrell, John C. Cheville, Matthew K. Tollefson - Cancer 2014 cited by 295

  18. Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma

    Authors: Niraj Shenoy, Tushar D. Bhagat, John C. Cheville, Christine M. Lohse, Sanchari Bhattacharyya, Alexander Tischer, Venkata R. Machha, Shanisha Gordon-Mitchell, Gaurav S. Choudhary, Li-Fan Wong, LouAnn Gross, Emily Ressigue, Bradley C. Leibovich, Stephen A. Boorjian, Ulrich Steidl, Xiaosheng Wu, Kith Pradhan, Benjamin A. Gartrell, Beamon Agarwal, Lance C. Pagliaro, Masako Suzuki, John M. Greally, Dinesh Rakheja, R. Houston Thompson, Katalin Suszták, Thomas E. Witzig, Yiyu Zou, Amit Verma - Journal of Clinical Investigation 2019 cited by 111

  19. Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

    Authors: R. Houston Thompson, Susan M. Kuntz, Bradley C. Leibovich, Haidong Dong, Christine M. Lohse, W. Scott Webster, Shomik Sengupta, Igor Frank, Alexander S. Parker, Horst Zincke, Michael L. Blute, Thomas J. Sebo, John C. Cheville, Eugene D. Kwon - Cancer Research 2006 cited by 870

  20. PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

    Authors: R. Houston Thompson, Haidong Dong, Christine M. Lohse, Bradley C. Leibovich, Michael L. Blute, John C. Cheville, Eugene D. Kwon - Clinical Cancer Research 2007 cited by 567

  21. Deepfake Histologic Images for Enhancing Digital Pathology

    Authors: Kianoush Falahkheirkhah, Saumya Tiwari, Kevin Yeh, Sounak Gupta, Loren Herrera-Hernandez, Michael McCarthy, Rafael E. Jiménez, John C. Cheville, Rohit Bhargava - Laboratory Investigation 2023 cited by 33

  22. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

    Authors: R. Houston Thompson, Michael D. Gillett, John C. Cheville, Christine M. Lohse, Haidong Dong, W. Scott Webster, Kent G. Krejci, John R. Lobo, Shomik Sengupta, Lieping Chen, Horst Zincke, Michael L. Blute, Scott E. Strome, Bradley C. Leibovich, Eugene D. Kwon - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 766

  23. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.

    Authors: Scott E. Strome, Haidong Dong, Hideto Tamura, Stephen G. Voss, Dallas B. Flies, Koji Tamada, Diva R. Salomão, John C. Cheville, Fumiya Hirano, Wei Lin, Jan L. Kasperbauer, Karla V. Ballman, Lieping Chen - 2003 cited by 492

  24. B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy

    Authors: Timothy J. Roth, Yuri Sheinin, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, Brant A. Inman, Amy E. Krambeck, Maureen E. Mckenney, R. Jeffrey Karnes, Michael L. Blute, John C. Cheville, Thomas J. Sebo, Eugene D. Kwon - Cancer Research 2007 cited by 269